Therapy Areas: Diabetes
16 November 2026 - Ambrosia Biosciences Inc, a drug discovery company developing next-generation oral small molecule therapies for obesity and other metabolic disorders, on Sunday announced nonclinica...
13 November 2026 - New York-based global type 1 diabetes (T1D) research and advocacy organisation Breakthrough T1D and the Walgreens Foundation announced on Thursday a new national partnership support...
29 October 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Thursday that it has received European Medicines Agency (EMA) validation for two marketing authorisation app...
29 October 2026 - Chinese pharmaceutical company Ascletis Pharma Inc (HKEX:1672) on Wednesday reported positive topline results from its US Phase II study evaluating ASC30, an oral small molecule GLP-...
16 October 2026 - Swedish medical device company VibroSense Dynamics AB (Spotlight Stock Market: VSD B), which develops tools for diagnosing nerve damage in the hands and feet, said on Friday it has r...
15 October 2026 - Clinical-stage biopharmaceutical company Viking Therapeutics Inc (NASDAQ:VKTX) announced on Wednesday the initiation of the SUNRISE Phase 3 clinical programme for oral VK2735, a dual...